12 results
Stage I - Redistribution
In a normal chest film with the patient standing erect, the pulmonary vessels
The pulmonary vascular ... In daily clinical ... during a period of CHF ... #Clinical #Radiology ... #CXR #CHF #Cephalization
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Clinical ... 38 degrees • Chills ... Blood cultures • CXR ... early disease) • CXR ... #Abscess #pulmonary
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... without other cause ... : Age>60, CKD, CHF ... fluid balance, and CXR ... with pulmonary
Bronchiectasis - Summary

What?
• Bronchiectasis is derived from the Greek words bronckos meaning airway and ectasis meaning
Chronic inflammation causes ... Fevers and/or chills ... Most Common Causes ... Physical stigmata of cor ... mycobacteria Treatment
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Unknown • 6-7 cases ... Organizing Pneumonia - Clinical ... - Imaging: • CXR ... Organizing Pneumonia Treatment ... Pneumonia #COP #BOOP #pulmonary
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
“the squeeze”) along ... with presence of pulmonary ... the determined cause ... #heartfailure #chf ... #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
effects in the treatment ... hallucinations, rashes/long-term ... tolerable • Limited clinical ... phlebitis, fever, chills ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... hallucinations, rashes/long-term ... Weaknesses: Limited clinical ... Coccidioidomycosis #pharmacology ... #management #treatment
Stage III - Alveolar edema
This stage is characterized by continued fluid leakage into the interstitium, which
After treatment ... redistribution of the pulmonary ... #Clinical #Radiology ... #CXR #CHF #Alveolar ... #Pulmonary #Edema
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Hypocomplementemia • Can cause ... salivary ducts Clinical ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic